1. Short title This Act may be cited as the Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act or the AMERICAN DRUGS Act . 2. FDA notification (a) In general The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs (referred to in this section as the Commissioner ), shall issue notifications to the Administrator of the Centers for Medicare & Medicaid Services, the Secretary of Defense, and the Secretary of Veterans Affairs upon a determination by the Commissioner that— (1) there are at least 2 approved generic drugs that are manufactured domestically, as described in subsection (b), each of which— (A) is approved pursuant to an application under section 505(j) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(j) ); and (B) references the same listed drug under paragraph (7) of such section 505(j); or (2) there are fewer than 2 approved generic drugs that are manufactured domestically— (A) approved pursuant to an application under section 505(j) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(j) ); and (B) that reference the same listed drug under paragraph (7) of such section 505(j) as another drug approved under such section 505(j); (3) paragraph (1)(B) may soon apply because the Commissioner has been notified that a holder of an approved application for a generic drug that is manufactured domestically, as described in subsection (b), plans to discontinue manufacturing, or expects an interruption of the manufacture of, such drug at an establishment described in subsection (b)(1)(B)